Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine During Elective Spinal Surgery for Postoperative Pain
IRCT20241010063322N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ketamine in spinal stenosis, spondylolisthesis and degenerative scoliosis, sponsored by Tehran University of Medical Sciences. Primary endpoint: Postoperative pain intensity. Started Nov 2024; status: completed.
02
Drugs
ketamine
03
Conditions
spinal stenosisspondylolisthesisdegenerative scoliosis
Beyond the preview
Go deeper on IRCT20241010063322N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241010063322N1.